Brief: Atrys Health To Buy Chilerad For 8.05 Mln Euros

Atrys Health SA

28/12/2022 06:46

Dec 28 (Reuters) - Atrys Health SA  ATRY.MC :
    * SAID ON TUESDAY IT SIGNED PURCHASE AGREEMENT FOR
ACQUISITION OF
100% OF COMPANY TELMED AND 100% OF COMPANY PRESTACIONES MEDICAS
E INVERSIONES CHAXA (CHILERAD), IN CHILE
    * AGGREGATE PRICE AMOUNTS TO 8.05 MILLION EUROS AS FIXED
PRICE, OF
WHICH 7.43 MILLION EUROS ARE PAID IN CASH 
    * 0.62 MILLION EUROS ARE PAID WITH THE DELIVERY OF 103,879
SHARES
AT A PRICE OF 5.98 EUROS PER SHARE AND VARIABLE PAYMENT
AMOUNTING TO 0.85 MILLION EUROS LINKED TO REACHING MINIMUM
EBITDA OF 1.01 MILLION EUROS IN 2022
    * IT IS ESTIMATED THAT CHILERAD WILL END THE 2022 FINANCIAL
YEAR
WITH TURNOVER OF 5.7 MILLION EUROS AND ADJUSTED EBITDA OF 1.01
MILLION EUROS, WITHOUT FINANCIAL DEBT
    * IT IS ESTIMATED THAT INTEGRATION OF CHILERAD IN
TELERADIOLOGY
OPERATIONS OF ATRYS IN CHILE WILL GENERATE SYNERGIES OF 0.4
MILLION EUROS DURING FINANCIAL YEAR 2023
    * ACQUISITION OF TELMED EXPECTED TO BE CARRIED OUT BEFORE
DECEMBER
31, 2022 AND ACQUISITION OF PRESTACIONES MEDICAS E INVERSIONES
CHAXA TO BE CARRIED OUT DURING THE FIRST QUARTER OF FISCAL YEAR
2023

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nCNM81SZBK
 Further company coverage:  ATRY.MC  
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))